InvestSMART

Pacific Edge Limited (ASX: PEB) - Announcements

Current share price for PEB : $0.185 0.005 (2.63%)+

ASX company news and announcements for Pacific Edge Limited (PEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pacific Edge Limited (PEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pacific Edge Limited (PEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pacific Edge Limited (PEB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$230 Pacific Edge Placement Upsized to NZ$16 Million 3 Jun 2025 8:36AM $0.075 $0.185 risen by 146.67%
$230 Trading Halt 30 May 2025 8:55AM $0.075 $0.185 risen by 146.67%
$230 Proposed issue of securities - PEB 30 May 2025 7:30AM $0.075 $0.185 risen by 146.67%
$230 Pacific Edge Launches NZ $20m Capital Raise 30 May 2025 7:30AM $0.075 $0.185 risen by 146.67%
$230 Pacific Edge Reports Resilient Performance in FY25 30 May 2025 7:30AM $0.075 $0.185 risen by 146.67%
$230 Pacific Edge FY25 Result to be Announced 30 May 2025 12 May 2025 7:31AM $0.080 $0.185 risen by 131.25%
$230 Triage Plus Set to Lift Pacific Edge's Economics 29 Apr 2025 10:12AM $0.075 $0.185 risen by 146.67%
$230 Pause in Trading 29 Apr 2025 9:47AM $0.075 $0.185 risen by 146.67%
$230 Medicare LCD Effective - Pacific Edge Seeks Recoverage 28 Apr 2025 7:31AM $0.110 $0.185 risen by 68.18%
$230 US COURT LACKS JURISDICTION TO HEAR PACIFIC EDGE CLAIM 24 Apr 2025 8:21AM $0.105 $0.185 risen by 76.19%
$230 Q4 25 Cxbladder Volumes Rise and Key Metrics Improve 4 Apr 2025 8:54AM $0.120 $0.185 risen by 54.17%
$230 Cxbladder Incorporated into AUA Clinical Guideline 28 Feb 2025 7:31AM $0.055 $0.185 risen by 236.36%
$230 Ongoing Disclosure Notice 28 Jan 2025 11:07AM $0.052 $0.185 risen by 255.77%
$230 Medicare LCD Effective Date Extended to 24 April 2025 28 Jan 2025 7:30AM $0.052 $0.185 risen by 255.77%
$230 Pacific Edge Release Quarterly Volumes for Q3 FY25 22 Jan 2025 7:30AM $0.057 $0.185 risen by 224.56%
$230 Novitas finalizes non-coverage determination 13 Jan 2025 9:08AM $0.140 $0.185 risen by 32.14%
$230 Trading Halt 10 Jan 2025 9:05AM $0.140 $0.185 risen by 32.14%
$230 Notification regarding unquoted securities - PEB 20 Dec 2024 1:55PM $0.135 $0.185 risen by 37.04%
$230 Notification of cessation of securities - PEB 20 Dec 2024 1:36PM $0.135 $0.185 risen by 37.04%
$230 Correction - HY25 Statements Unaudited 26 Nov 2024 9:12AM $0.100 $0.185 risen by 85%
$230 Financial Results for the Half Year to 30 September 2024 26 Nov 2024 7:30AM $0.100 $0.185 risen by 85%
$230 Interim Financial Result to be Announced 26 November 2024 6 Nov 2024 7:30AM $0.130 $0.185 risen by 42.31%
$230 Pacific Edge Release Quarterly Volumes for Q2 FY25 9 Oct 2024 7:39AM $0.120 $0.185 risen by 54.17%
$230 Results of Meeting 24 Sep 2024 2:01PM $0.145 $0.185 risen by 27.59%
$230 Chair's Address to Shareholders 24 Sep 2024 11:04AM $0.150 $0.185 risen by 23.33%

101 - 125 of 267 results

Page 5 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.